Table 1.
Demographic and clinical data of patients and controls with imaging available 3 months after surgery.
| Left TLE | Right TLE | Controls | Significance | |
|---|---|---|---|---|
| Subjects (n) | 26 | 22 | 17 | – |
| Sex (Male/Female) | 13/13 | 2/20 | 9/8 | Chi2 (Left TLE; Controls) = 0.035 p (Left TLE; Controls) = 0.850 Chi2 (Right TLE; Controls) = 9.106 p (Right TLE; Controls) = 0.003 |
| Age at baseline scan | 35.86 ± 9.57 | 39.83 ± 12.26 | 40.06 ± 11.06 | t (Left TLE; Controls) = -1.318 p (Left TLE; Controls) = 0.195 t (Right TLE; Controls) = -0.060 p (Right TLE; Controls) = 0.953 |
| Onset | 16.19 ± 10.93 | 14.93 ± 10.75 | – | – |
| Age at surgery | 36.52 ± 9.62 | 41.00 ± 12.42 | – | – |
| Epilepsy Duration | 20.33 ± 13.67 | 26.07 ± 13.35 | – | – |
| Status Epilepticus (n) | 3 | 1 | – | – |
| Secondary generalised seizures (n) | 20 | 14 | – | – |
| Hippocampal Sclerosis (n) | 18 | 11 | – | – |
| Seizure-Free for 5 years (n) | 11 | 5 | – | – |
| Seizure recurrence (n) | 11 | 12 | – | – |